Advertisement

Topics

Synergy Pharmaceuticals Announces Pricing of Offering of Common Stock and Warrants

09:27 EST 13 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Synergy Pharmaceuticals Inc. (Nasdaq:SGYP), a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal therapies, today announced the pricing of its underwritten offering of 21,705,42...

Other Sources for this Article

Synergy Pharmaceuticals Inc.
Gem Hopkins, 212-584-7610
VP, Investor Relations and Corporate Communications
ghopkins@synergypharma.com

NEXT ARTICLE

More From BioPortfolio on "Synergy Pharmaceuticals Announces Pricing of Offering of Common Stock and Warrants"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...